Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
Published 2016 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Hepcidin Response to Iron Therapy in Patients with Non-Dialysis Dependent CKD: An Analysis of the FIND-CKD Trial
Authors
Keywords
Ferritin, Anemia, Chronic kidney disease, Intravenous injections, Inflammation, Oral administration, Medical dialysis, Iron deficiency
Journal
PLoS One
Volume 11, Issue 6, Pages e0157063
Publisher
Public Library of Science (PLoS)
Online
2016-06-09
DOI
10.1371/journal.pone.0157063
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Correlates of serum hepcidin levels and its association with cardiovascular disease in an elderly general population
- (2016) Raimund Pechlaner et al. CLINICAL CHEMISTRY AND LABORATORY MEDICINE
- Oral iron supplements increase hepcidin and decrease iron absorption from daily or twice-daily doses in iron-depleted young women
- (2015) D. Moretti et al. BLOOD
- Anemia of Inflammation
- (2014) Elizabeta Nemeth et al. HEMATOLOGY-ONCOLOGY CLINICS OF NORTH AMERICA
- Effects of additional iron doses on hepcidin-25 level in hemodialysis patients without evident iron deficiency
- (2014) Lavinia Oltiţa Brătescu et al. INTERNATIONAL UROLOGY AND NEPHROLOGY
- Serum hepcidin-25 and response to intravenous iron in patients with non-dialysis chronic kidney disease
- (2014) Sourabh Chand et al. JOURNAL OF NEPHROLOGY
- Identification of erythroferrone as an erythroid regulator of iron metabolism
- (2014) Léon Kautz et al. NATURE GENETICS
- FIND-CKD: a randomized trial of intravenous ferric carboxymaltose versus oral iron in patients with chronic kidney disease and iron deficiency anaemia
- (2014) I. C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- The Relation of Hepcidin to Iron Disorders, Inflammation and Hemoglobin in Chronic Kidney Disease
- (2014) Lucile Mercadel et al. PLoS One
- Hepcidin-25, Mean Corpuscular Volume, and Ferritin as Predictors of Response to Oral Iron Supplementation in Hemodialysis Patients
- (2014) Kazuya Takasawa et al. Nutrients
- Manipulation of the hepcidin pathway for therapeutic purposes
- (2013) E. Fung et al. HAEMATOLOGICA
- Serum Hepcidin in Haemodialysis Patients: Associations with Iron Status and Microinflammation
- (2013) Y Xu et al. JOURNAL OF INTERNATIONAL MEDICAL RESEARCH
- The FIND-CKD study—a randomized controlled trial of intravenous iron versus oral iron in non-dialysis chronic kidney disease patients: background and rationale
- (2013) Iain C. Macdougall et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Second round robin for plasma hepcidin methods: First steps toward harmonization
- (2012) Joyce J.C. Kroot et al. AMERICAN JOURNAL OF HEMATOLOGY
- Hepcidin levels predict nonresponsiveness to oral iron therapy in patients with iron deficiency anemia
- (2012) David B. Bregman et al. AMERICAN JOURNAL OF HEMATOLOGY
- Association between Albuminuria, Kidney Function, and Inflammatory Biomarker Profile in CKD in CRIC
- (2012) J. Gupta et al. Clinical Journal of the American Society of Nephrology
- Hepcidin-25 in Chronic Hemodialysis Patients Is Related to Residual Kidney Function and Not to Treatment with Erythropoiesis Stimulating Agents
- (2012) Neelke C. van der Weerd et al. PLoS One
- Hepcidin: clinical utility as a diagnostic tool and therapeutic target
- (2011) Daniel W. Coyne KIDNEY INTERNATIONAL
- Current Status of the Measurement of Blood Hepcidin Levels in Chronic Kidney Disease
- (2010) I. C. Macdougall et al. Clinical Journal of the American Society of Nephrology
- Hepcidin-25 is a marker of the response rather than resistance to exogenous erythropoietin in chronic kidney disease/chronic heart failure patients†
- (2010) Karien van der Putten et al. EUROPEAN JOURNAL OF HEART FAILURE
- Intra-individual variability in serum hepcidin precludes its use as a marker of iron status in hemodialysis patients
- (2010) Bradley A. Ford et al. KIDNEY INTERNATIONAL
- Hepcidin is not useful as a biomarker for iron needs in haemodialysis patients on maintenance erythropoiesis-stimulating agents
- (2010) N. Tessitore et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Quantitation of hepcidin in serum using ultra-high-pressure liquid chromatography and a linear ion trap mass spectrometer
- (2010) Sukhvinder S. Bansal et al. RAPID COMMUNICATIONS IN MASS SPECTROMETRY
- Hepcidin Assays: Ironing Out Some Details
- (2009) J. Malyszko Clinical Journal of the American Society of Nephrology
- Hepcidin--A Potential Novel Biomarker for Iron Status in Chronic Kidney Disease
- (2009) J. Zaritsky et al. Clinical Journal of the American Society of Nephrology
- Hepcidin for Clinicians
- (2009) B. Young et al. Clinical Journal of the American Society of Nephrology
- Serum hepcidin concentration in chronic haemodialysis patients: associations and effects of dialysis, iron and erythropoietin therapy
- (2009) G. Weiss et al. EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
- Results of the first international round robin for the quantification of urinary and plasma hepcidin assays: need for standardization
- (2009) J. J.C. Kroot et al. HAEMATOLOGICA
- Plasma hepcidin levels are elevated but responsive to erythropoietin therapy in renal disease
- (2009) Damien R. Ashby et al. KIDNEY INTERNATIONAL
- Serum hepcidin-25 levels in patients with chronic kidney disease are independent of glomerular filtration rate
- (2009) H. P.E. Peters et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- New and old players in the hepcidin pathway
- (2008) C. Camaschella et al. HAEMATOLOGICA
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now